Alflutinib Uses, Dosage, Side Effects and more
Alflutinib is under investigation in clinical trial NCT03452592 (Efficacy and Safety of Alflutinib in Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients With T790M).
Trade Name | Alflutinib |
Generic | Alflutinib |
Type | |
Formula | C28H31F3N8O2 |
Weight | Average: 568.605 Monoisotopic: 568.252206759 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |